CEP-33779

CEP-33779

Catalog Number:
L002369054APE
Mfr. No.:
APE-A4146
Price:
$421
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          CEP-33779, is a highly selective, orally active inhibitor of Janus kinase 2 (JAK2). When evaluate against the other members of the JAK family, CEP-33779 demonstrates varying degrees of selectivity from >40-fold versus JAK1 to >800-fold against TYK2. In a cellular system, CEP-33779 is shown to inhibit JAK2 in irf-bla TF-1 cells utilizing the GeneBLAzer reporter assay. It is also able to mitigate several immune parameters associated with SLE advancement, including the protection and treatment of mice with lupus nephritis. The ability of CEP-33779 to suppress growth of colorectal tumors by inhibiting the IL-6/JAK2/STAT3 signaling suggests a potential therapeutic utility of JAK2 inhibitors in multiple tumors types, particularly those with a strong inflammatory component.

      • Properties
        • Alternative Name
          CEP 33779,CEP33779; N-[3-(4-methylpiperazin-1-yl)phenyl]-8-(4-methylsulfonylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine
          CAS Number
          1257704-57-6
          Molecular Formula
          C24H26N6O2S
          Molecular Weight
          462.57
          Appearance
          A solid
          Purity
          98.00%
          Solubility
          ≥23.15 mg/mL in DMSO with gentle warming; insoluble in EtOH
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Garcia-Diaz A, Shin DS, et al. "Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression." Cell Rep. 2017 May 9;19(6):1189-1201. PMID:28494868

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.